Literature DB >> 17373154

Urticarial vasculitis secondary to paroxetine.

John Patrick Welsh1, Carrie Ann Cusack, Christine Ko.   

Abstract

Paroxetine (Paxil) is a widely prescribed antidepressant of the selective serotonin reuptake inhibitor (SSRI) class for which multiple cutaneous adverse effects have been reported, including urticaria, ecchymoses, vasculitis, and pruritus. In contrast, fluoxetine (Prozac) is the only SSRI previously reported to cause urticarial vasculitis. Urticarial vasculitis is a chronic disorder marked by recurrent episodes of erythematous, indurated wheals that histologically manifest the features of leukocytoclastic vasculitis. This case represents the first reported incidence of paroxetine-induced urticarial vasculitis, and highlights the need to consider the entire SSRI class as s as a potential cause of the condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17373154

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

1.  Sibutramine (reductil®)-induced cutaneous leukocytoclastic vasculitis: a case report.

Authors:  You Jin Ha; You Jin Han; You Won Choi; Ki Bum Myung; Hae Young Choi
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

2.  Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study.

Authors:  Li-Yu Hu; Chia-Jen Liu; Ti Lu; Tsung-Ming Hu; Chia-Fen Tsai; Yu-Wen Hu; Cheng-Che Shen; Yu-Sheng Chang; Mu-Hong Chen; Chung-Jen Teng; Huey-Ling Chiang; Chiu-Mei Yeh; Vincent Yi-Fong Su; Wei-Shu Wang; Pan-Ming Chen; Tzeng-Ji Chen; Tung-Ping Su
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.